Common Contracts
7 similar null contracts by WuXi PharmaTech (Cayman) Inc.
EX-99.(B)(8) 10 d86213dex99b8.htm EX-99.(B)(8) Exhibit (b)-(8) EXECUTION VERSION CONFIDENTIAL EQUITY COMMITMENT LETTER August 14, 2015 New WuXi Life Science Holdings Limited New WuXi Life Science Limited Address: 288 Fute Zhong Road The China...New York • May 5th, 2020
This letter agreement sets forth the commitment of Group & Cloud Limited, an exempted company organized and existing under the Laws of the Cayman Islands (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a direct wholly-owne
EQUITY COMMITMENT LETTER August 14, 2015WuXi PharmaTech (Cayman) Inc. • September 1st, 2015 • Pharmaceutical preparations • New York
This letter agreement sets forth the commitment of Temasek Life Sciences Private Limited, a limited company organized and existing under the Laws of Singapore (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a direct wholly
EQUITY COMMITMENT LETTER August 14, 2015WuXi PharmaTech (Cayman) Inc. • September 1st, 2015 • Pharmaceutical preparations • New York
This letter agreement sets forth the commitment of Ping An Life Insurance Company of China, Ltd. (Registration No. 100000000037463, a joint stock limited company organized and existing under the Laws of the People’s Republic of China (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Compa
EQUITY COMMITMENT LETTER August 14, 2015WuXi PharmaTech (Cayman) Inc. • September 1st, 2015 • Pharmaceutical preparations • New York
This letter agreement sets forth the commitment of ABG II-WX Limited, a company limited by shares and incorporated and existing under the Laws of the British Virgin Islands (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a
EQUITY COMMITMENT LETTER August 14, 2015WuXi PharmaTech (Cayman) Inc. • September 1st, 2015 • Pharmaceutical preparations • New York
This letter agreement sets forth the commitment of Boyu Capital Fund II, L.P., an exempted limited partnership formed under the Laws of the Cayman Islands (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a direct wholly-own
EQUITY COMMITMENT LETTER August 14, 2015WuXi PharmaTech (Cayman) Inc. • September 1st, 2015 • Pharmaceutical preparations • New York
This letter agreement sets forth the commitment of Group & Cloud Limited, an exempted company organized and existing under the Laws of the Cayman Islands (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger as a direct wholly-owne
EQUITY COMMITMENT LETTER August 14, 2015WuXi PharmaTech (Cayman) Inc. • September 1st, 2015 • Pharmaceutical preparations • New York
This letter agreement sets forth the commitment of Hillhouse Capital Fund II, L.P., an exempted limited partnership organized and existing under the Laws of the Cayman Islands (the “Sponsor”), on the terms and subject to the conditions contained herein, to purchase, directly or indirectly, certain equity interests of New WuXi Life Science Holdings Limited, an exempted company with limited liability incorporated under the Laws of the Cayman Islands (“Holdco”). It is contemplated that, pursuant to that certain Agreement and Plan of Merger, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Merger Agreement”), among WuXi PharmaTech (Cayman) Inc. (the “Company”), New WuXi Life Science Limited, a direct wholly-owned Subsidiary of Holdco (“Parent”), and WuXi Merger Limited, a direct wholly-owned Subsidiary of Parent (“Merger Sub”), Merger Sub will merge with and into the Company (the “Merger”), with the Company surviving the Merger a
